This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Pharmaceutical Caps and Closures Market

Market Insights on Pharmaceutical Caps and Closures covering sales outlook, demand forecast & up-to-date key trends

Pharmaceutical Caps and Closures Market by Product type (Screw Caps & Closure, Snap Caps & Closure, Push-Pull Caps & Closure, Stopper & Seals), Functionality (Child Resistant, Tamper-evident), Material, Drug Modality, Therapeutic class, End Users & Region - Forecast to 2021-2031

Key Highlights From Report

  • Which is the most lucrative market for pharmaceutical caps and closures?

    The U.S. currently leads the global market for pharmaceutical caps and closures. Sales in the U.S. will account for over 89% of the North America market throughout the forecast period.

  • Which is the most commonly used type of pharmaceutical caps and closures?

    Screwcap and closures have emerged dominant in terms of product type and are expected to account for more than 46% of the market through 2031.

  • Which is the most common application for pharmaceutical caps and closures?

    Anti-cancer drugs are exhibiting faster growth in demand at 7.5% CAGR for pharmaceutical caps and closures.

  • Which drug modality contributes to maximum sales of pharmaceutical caps and closure?

    Small molecule drug modalities are showing consistency in growth and are expected to account for approximately 60% of the global market by 2031. Rising demand for standardization will drive sales in this category.

  • Who is the leading end-user of pharmaceutical caps and closures?

    Pharmaceutical and biotechnology companies are leading end-users in the market and are expected to hold a share of 52.5% through 2021 owing to their advanced medical facilities and higher footfall of patients.

  • Which materials are preferred for the production of pharmaceutical caps and closures?

    Plastics will account for more than 64% of the market in 2031 owing to their flexibility in function and low costs of production and sourcing.

Customize this Report

Let us know your requirement to get
100% FREE customization

Key Points Covered in Pharmaceutical Cap and Closure Market Study

  • Market estimates and forecast 2015-2031
  • Key drivers and restraints impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Pharmaceutical Caps and Closures Market and How to Navigate
  • Recommendation on Key Winning Strategies

2016-2020 Pharmaceuticals Caps and Closures Market Outlook Compared to 2021-2031 Forecast

Until recently, owing to a lack of awareness about safety concerns, the production of pharmaceutical caps and closures was fairly limited. According to Future Market Insights FMI), the sales of pharmaceutical caps and closures have grown at a 4.7% CAGR between 2016 and 2020.

The increasing demand for safe and easy packaging has encouraged innovations in the field of pharmaceutical caps and the closures market. The demand for child-proof packaging owing to concerns over accidental consumption is rising. This also will have a positive impact on the market.

According to the National Health Service (NHS), a majority of children under five years are affected by unwanted harmful drugs owing to improper closing of containers.

With growing economies and the expansion of health care and insurance systems, the demand for pharmaceutical products is escalating strongly. It is estimated that the global pharmaceutical market will grow at 3-6% annually in the coming years.

Focus on effective packaging to minimize the risk of accidents and spoilage of pharmaceutical products, the demand in the market is expected to increase.  In the U.S., the spending on medicines is increasing owing to new product adoption. Medical spending in Japan exceeded US$85 Bn in 2019. The same for China touched US$136 Bn.

The usage of medicines has jumped by 24% in 2020 as compared to 2015. Developed economies will continue to use a larger volume of prescribed medicines. Emerging countries will use more generics and over-the-counter alternatives.

With pharmaceutical spending consistently rising in developed countries, the demand for pharmaceutical caps and closures is expected to rise.

The COVID-19 pandemic has changed priorities in the national healthcare process and spending. However, it is considered to have a short-term negative impact on the pharmaceutical caps and closures market. Future Market Insights expects the global pharmaceuticals caps and closures market to rise at 5.7 % CAGR between 2021 and 2031.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How are Light Weight Packaging Formats Affecting the Pharmaceutical caps and Closures Market?

Lightweight packaging material have a higher acceptance rate among consumers. Lightweight closures made from resins, which results in lower plastic usage, while meeting the need of environment friendly products.

Considering both economic and social benefits, light-weight packaging has become increasingly acceptable, while innovation and research are seen as key to the future of the market.

How are Investments in Product Development Influencing Growth?

Innovation in the field of plastic packaging has been aiding new product launches in the market. Researchers are focusing on the objective of reduction in development costs.

Extensive research has been conducted using samples from across the world to create unique products which are cost friendly, profitable, and made with limited resources.

For Instance, In March 2021, Drug Plastics & Glass Co Inc. filed a patent for new closure designs. The SecuRx Dosage Cap is ideal for cough syrups, antacids, vitamins, antibiotics, cannabis beverages, and more, and they deliver accurate, user-friendly liquid doses which can be mass produced at a lower cost.

Innovations such as these are expected to have positive impact on the market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

How are Stringent Regulations Restricting Market Growth?

Stringent rules and regulations associated with the grade of plastics used in end-use industries, especially in the food and beverages and pharmaceuticals industries might hamper market growth.

Also, in the U.S. regulations enacted by the Food and Drug Administration (FDA) have made it compulsory to implement child-resistant closures. This will create lucrative prospects for sales in the pharmaceutical industry.

However, smaller companies might find it difficult to adhere to such stringent regulations. Machineries required for ascertaining stringent guidelines are often cost-intensive, which might discourage smaller players. This in turn can have a negative impact on the market.

What are the Key Opportunities for Pharmaceutical Cap and Closure Manufacturers?

Today, consumers are looking for products that are easy to access, easy to use, with higher preference for  self resealing offerings. These factors are creating notable opportunities for manufacturer to develop consumer-friendly products.

Increasing investments in the healthcare sector in emerging countries is anticipated to boost the demand for pharmaceutical caps & closures.  Local and regional players are expanding their distribution networks and manufacturing facilities to boost their business portfolio across the globe.

Increasing government initiatives for research and development is expected to provide create significant opportunities in the pharmaceutical caps & closures market.

Country-wise Insights

How Lucrative is the Opportunity in the U.S?

In the U.S., the spending on medicines has steadily increased over the years , driving the adoption of new cap and closure offerings. The U.S. will hold over 89% of the pharmaceutical caps and closures market in North America. Also, regulations implemented by the FDA to ascertain child-resistant closures in the pharmaceutical industry have contributed to growth prospects.

Implementation of such laws are boosting research and development among manufacturers in North America. The year 2020 also witnessed vaccine launches for the COVID-19 pandemic. Increasing production and sales of vaccines will drive the pharmaceutical caps & closures market.

Moreover, the increasing prevalence of chronic diseases like cardiovascular disorders, cancer, and others is fuel demand for for various medications. This will in turn fuel the demand for effective packaging solutions in the pharmaceutical sector, creating opportunities for the pharmaceutical caps and closure sales.

What are the Factors Driving Revenue Generation in the U.K.?

The U.K. will account for over 25% of the Europe market through the assessment period ending in 2031. Common tech developments, the demand for extensive product portfolios, and improvements in drug development pipelines and production capacities are key factors speeding growth in the U.K. market for pharmaceutical caps and closures.

New acquisitions have been driven by the need to widen portfolios for nonexclusive clean injectables in the U.K. market.  For Instance, in January 2020, Cyrano Berry launched its advanced molding technology, to create extremely lightweight components to deliver reliable performance to safeguard product integrity, offer ease drug administration, and improve patient safety.

What are the Factors Restricting Pharmaceutical Caps and Closure Production in Germany?

The Germany market will exhibit a 6.7% CAGR thoughout the forecast period. Regulatory guidelines are relatively stricter in Germany. As a result, achieving approvals is harder. The EMA guideline covers the exact requests for packaging materials which is in direct contact pharma products or drugs.

These guidelines need to be met for new registration applications. As a result of stringent guidelines, elastomeric closures are increasingly used in injectable pharmaceutical products and delivery systems to ensure component functionality and suitability of parenteral products.

Plastic packaging systems create concerns associated to potential safety effects with the production of drugs and biopharmaceuticals. As a result, stringent regulation for all type of closures in Germany is restraining the market.

Favorable Policies Driving Japan Market

Increasing healthcare spending has improved the quality of healthcare, while boosting the demand for pharmaceutical products in countries like Japan. The Japan market will accounts for more than 45% of the sales registered East Asia market in 2021.

In Japan, the total annual pharmaceutical spending equals US$93 billion. Moreover, the government of Japan provides for healthcare spending of around 40% via the national insurance schemes. Japan’s pharmaceutical sector has been forecast to grow considerably in the coming years, paving way for the expansion of the pharmaceutical caps and closures market.

What is Scope of Growth of Pharmaceutical Caps and Closures Market in Argentina?

Increasing investments in the healthcare sector is anticipated to boost the demand of pharmaceutical caps & closures. Increasing government initiatives for research and development is expected to provide significant opportunities in Argentina.

The market for pharmaceutical caps and closures in Argentina is exhibiting 4% CAGR, and is expected to account for more than 11% of the Latin America market throughout the projection period.  Encouraged by lucrative prospects, several market players are likely to expand their presence in the country.

For Instance, in September 2020, Bericap GmbH and Co KG established a new plant in Argentina and started a production facility in Malaysia as a hub for further expansion in Southeast Asia.

Pharmaceutical Caps and Closures Market Download Report Brochure

Category-wise Insights

Why is Child Resistant Driving Revenue by Functionality?

A relatively higher adoption rate is witnessed in child resistance closures owing to their effectiveness in preventing accidental consumption. The segment is expected to account for 61% market share in 2021.

Also, lower costs of these closures result in higher revenue generation in the global pharmaceuticals caps and closures market. However, tamper-resistant products will reflect a higher rate of growth owing to concerns over counterfeiting.

What is the Market Share of Screw Caps and Closure?

Screw caps and closures will continue to dominate the market during the forecast period. According to Future Market Insights, the segment is expected to hold around 46% of the market share through the end of 2031.

Screw caps and closures offer various benefits to manufacturers in the supply chain and are helpful in patient compliance. Besides this, they offer help in offering longer shelf life and sustainability of products.

Why are Plastics Preferred for Pharmaceutical Caps and Closures?

Plastic closures are lightweight, cost-effective, and easy to manufacture which will enable the plastic segment to account for over 64% of the market by the end of 2031. Lightweight packaging materials have higher acceptance rates among consumers.

Lightweight closure made from resins results in lower plastic usage while also complying with the recent rise in demand for environment-friendly products.

On the other hand, the manufacturing cost is also reduced due to the usage of resin in lightweight caps. Therefore, considering both economic and social benefits, offering lightweight has become a key aspect for production. This will also influence the material used for manufacturing pharmaceutical caps and closures.

How are Prescription (Rx) Caps and Closures Set to Fare?

Most pharmaceutical and biopharmaceutical drugs for chronic diseases are available only with prescriptions. As a result, prescribed drug closures will account for a market share of 76%  by the end of 2031.

Over-the-counter (OTC) alternatives are likely to witness increasing opportunities, especially in developing countries, owing to easier access to consumers. The trend is likely to continue in the upcoming years, fuelling sales in the OTC segment.

How are Small Molecule Drug Modalities Contributing to Growth?

Most of pharmaceutical companies are focusing on the development of small molecule and biopharmaceutical packaging with improved compatibility with most container closure designs.

This segment is estimated to be valued at US$ 2.33 Bn by the end of 2031. Research into biopharmaceuticals will also create important growth opportunities.

Why are Pharmaceutical & Biotechnology Exhibiting High Demand for Pharmaceutical Caps and Closures?

Most pharma and biotech companies are focusing on pharma products with higher brand awareness which is particularly true in developed countries. Pharmaceutical and biotechnology companies are likely to account for over 55% of sales in the market in 2021.

Which Therapeutic Class is Aiding Increasing Sales of Pharmaceutical Caps and Closures?

Anticancer drugs currently lead the market in terms of therapeutic class, accounting for a share of over 20% in 2021. The increasing prevalence of cancer around the world will fuel demand in the segment.

According to the International Agency for Research on Cancer (IARC), by 2040, the world is expected to register 27.5 million new cancer cases and 17.3 million cancer deaths.  According to the WHO, the risk of developing cancer before the age of 75 years is about 20.2% and the risk of dying from cancer before the age of 75 years is about 10.6%.

The demand for cancer treatment medications is increasing at a high pace, which is expected to create growth opportunities in the market. The demand for pharmaceutical caps and closures for anti-cancer drugs is forecast to rise at a CAGR of 7.5% between 2021 and 2031.

Competitive Landscape

Manufacturers in the pharmaceutical caps and closures market are primarily aiming to carry out strategic collaborations and R&D to consolidate growth in a competive and fragmented market.

For Instance, In November 2019, the MENSHEN Gmbh launched a new sustainable closure solution that was specially designed for the pharmaceuticals industry.

In January 2020, Berry group launched a new product Cyrano Berry’s advanced molding technology to create extremely lightweight components, which still deliver reliable performance to safeguard product integrity, ease drug administration, and improve patient safety.

In October 2020, West Pharmaceutical Serivese launched Vial2Bag Advanced 20mm Admixture Device, which enables reconstitution and transfer of a drug between a vial and an IV bag.

The company is strategically making promotional plans for its established prescription brands to increase their awareness within the prescription market Its ‘Get Old’ campaign also makes a frequent appearance on the main company feeds and through its own Twitter and Facebook page.

Some of the leading companies in the pharmaceutical caps and closures market include:

  • Berry Global Inc.              
  • Amcor Plc
  • Aptar, Inc.
  • Closure Systems International, Inc.
  • O.Berk Company, LLC
  • Bericap GmbH and Co KG
  • UNITED CAPS
  • CL Smith Company
  • Georg MENSHEN GmbH & Co. KG
  • WestRock Company
  • West Pharmaceutical Services, Inc
  • Drug Plastics & Glass Co Inc.
  • Gerresheimer AG
  • DWK Life Sciences GmbH
  • Parekhplast India Limited
  • Parshva Exim Limited

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.

Scope of the Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

USD billion for Value

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa

Key Segments Covered

Product, Functionality, Material, Availability, Drugg Modality, Therapeutic Class, End-Users, and Region

Key Companies Profiled

  • Berry Global Inc               
  • Amcor Plc
  • Aptar, Inc.
  • Closure Systems International, Inc.
  • O.Berk Company, LLC
  • Bericap GmbH and Co KG
  • UNITED CAPS
  • CL Smith Company
  • Georg MENSHEN GmbH & Co. KG
  • WestRock Company
  • West Pharmaceutical Services, Inc
  • Drug Plastics & Glass Co Inc.
  • Gerresheimer AG
  • DWK Life Sciences GmbH
  • Parekhplast India Limited
  • Parshva Exim Limited

 

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Phramacutical caps and Closures Services Market by Category

Product type

  • Screw Caps & Closure
  • Snap Caps & Closure
  • Push-Pull Caps & Closure
  • Stopper & Seals
  • Others

Functionality

  • Child Resistant
  • Tamper-evident

Material type

  • Plastic
  • Elastomer
  • Metal

Avalability

  • Prescription (Rx) Pharmaceuticals
  • "Over-the-Counter (OTC) Pharmaceuticals"

Drug Modality

  • Small Molecule (Synthetic Drugs)
  • Biopharmaceuticals

Therapeutic class

  • Anticancer Drugs
  • Anti-infective Drugs
  • Anti-viral Drugs
  • Anti-bacterial Drugs
  • Anti-fungal Drugs
  • Others
  • Cardiovascular Drugs
  • Anti-inflammatory Drugs
  • Analgesics Drugs
  • Anti-diabetics
  • Ophthalmic Drugs
  • Neurological Drugs
  • Others

End Users

  • Pharmaceutical & Biotechnology Companies
  • Contract Manufacturing  Organizations (CMO)
  • Contract Research Organizations (CRO)
  • Academic & Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

From 2022 to 2032, the pharmaceutical caps and closures market is poised to grow at a CAGR of 5.7%

By 2032, the pharmaceutical caps and closures market is expected to reach US$ 4 Billion

The U.S is considered highly lucrative, accounting for over 89% of the North American market

Pharmaceutical and biotechnology companies are the most prominent end users, capturing 52.5% revenue

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Packaging Innovation / Development Trends

    3.3. Light weight packaging trends

    3.4. Sustainable packaging trends

    3.5. Smart connected packaging trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP outlook

        4.1.2. Global Healthcare Outlook

        4.1.3. Global Healthcare Expenditure Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Advanced Therapeutic Product Launches with Injectable Formulations 

        4.2.2. Packaging Material and Technological Advancements

        4.2.3. COVID19 Pandemic Emergence

        4.2.4. Cost of the Caps & Closures   

        4.2.5. Increases Prevalence of Chronic Disease 

        4.2.6. Regulatory Policies of Tamper Evident & Child Resistance Packaging 

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities 

    4.4. Value Chain Analysis 

5. Market Context

    5.1. Global Consumption Analysis, By Countries

    5.2. Product USPs/ Features

    5.3. Product  Adoption / Usage Analysis

    5.4. Product Adoption Vs. Therapeutic Class  Matrix Analysis

    5.5. Promotional Strategies, Key Manufacturers

    5.6. Regulatory Scenario

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Product Type

        6.4.2. Revenue By Therapeutic Class

        6.4.3. Revenue By End User

        6.4.4. Revenue By Region

    6.5. 2021 Market Scenario

    6.6. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Pharmaceutical Caps & Closure Market Demand (In Volume Units) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market (Volume) Analysis, 2016-2020

    7.2. Current and Future Market (Volume) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute Opportunity Analysis

            7.2.2.1. By Product Type

            7.2.2.2. By Functionality 

            7.2.2.3. Therapeutic Class

            7.2.2.4. By End User

            7.2.2.5. By Region

8. Global Pharmaceutical Caps & Closure Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product Type

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global Pharmaceutical Caps & Closure Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Opportunity Analysis, 2021-2031

10. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Product Type 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (units) Analysis By Product Type, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) and Volume (units) Analysis and Forecast By Product Type, 2021-2031

        10.3.1. Screw Caps & Closure 

        10.3.2. Snap Caps & Closure 

        10.3.3. Push-Pull Caps & Closure

        10.3.4. Stopper & Seals

        10.3.5. Others 

    10.4. Market Attractiveness Analysis By Product Type

11. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Functionality

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Functionality, 2016-2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Functionality, 2021-2031

        11.3.1. Child Resistant

        11.3.2. Tamper evident

        11.3.3. Child Resistant Tamper evident

        11.3.4. Others

    11.4. Market Attractiveness Analysis By Functionality

12. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Material

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Material, 2016-2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Material, 2021-2031

        12.3.1. Plastics 

            12.3.1.1. Polypropylene

            12.3.1.2. High Density Poly Ethylene (HDPE)

            12.3.1.3. Low-density polyethylene (LDPE)

            12.3.1.4. Cyclic Olefin Copolymer (COC)

            12.3.1.5. Others

        12.3.2. Elastomer 

            12.3.2.1. Synthetic Elastomer (Petroleum)

            12.3.2.2. Natural Elastomer (Rubber)

        12.3.3. Metal 

            12.3.3.1. Aluminium

            12.3.3.2. Tinplate steel 

    12.4. Market Attractiveness Analysis By Material

13. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Availability

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis By Availability, 2016-2020

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Availability, 2021-2031

        13.3.1. Prescription (Rx) Pharmaceuticals 

        13.3.2. Over-the-Counter (OTC) Pharmaceuticals 

    13.4. Market Attractiveness Analysis By Availability

14. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Drug Modality

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Analysis By Drug Modality, 2016-2020

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Modality, 2021-2031

        14.3.1. Small Molecule (Synthetic Drugs)

        14.3.2. Biopharmaceuticals 

            14.3.2.1. Recombinant Peptides & Proteins 

            14.3.2.2. Monoclonal Antibodies (mAb)

            14.3.2.3. Vaccines 

            14.3.2.4. Gene Therapeutics 

            14.3.2.5. Cell & Gene Therapy (CGT)

            14.3.2.6. Antibody-drug Conjugate (ADC) 

    14.4. Market Attractiveness Analysis By Drug Modality

15. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Class

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Mn) Analysis By Therapeutic Class, 2016-2020

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapeutic Class, 2021-2031

        15.3.1. Anticancer Drugs

        15.3.2. Anti-infective Drugs 

            15.3.2.1. Anti-viral Drugs 

            15.3.2.2. Anti-bacterial Drugs 

            15.3.2.3. Anti-fungal Drugs

            15.3.2.4. Others

        15.3.3. Cardiovascular Drugs 

        15.3.4. Anti-inflammatory Drugs 

        15.3.5. Analgesics Drugs 

        15.3.6. Anti-diabetics 

        15.3.7. Ophthalmic Drugs

        15.3.8. Neurological Drugs

        15.3.9. Others 

    15.4. Market Attractiveness Analysis By Therapeutic Class

16. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By End User

    16.1. Introduction / Key Findings

    16.2. Historical Market Size (US$ Mn) Analysis By End User, 2016-2020

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031

        16.3.1. Pharmaceutical & Biotechnology Companies

        16.3.2. Contract Manufacturing Organizations (CMO)

        16.3.3. Contract Research Organizations (CRO)

        16.3.4. Academic & Research Institutes

    16.4. Market Attractiveness Analysis By End User

17. Global Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031, By Region

    17.1. Introduction

    17.2. Historical Pharmaceutical Caps & Closure Market (US$ Mn) and Volume (units)  Analysis By Region, 2015 - 2019

    17.3. Current Pharmaceutical Caps & Closure Market (US$ Mn) and Volume (units)  Analysis and Forecast By Region, 2020 - 2030

        17.3.1. North America

        17.3.2. Latin America

        17.3.3. Europe

        17.3.4. East Asia

        17.3.5. South Asia

        17.3.6. Oceania

        17.3.7. Middle East and Africa (MEA)

    17.4. Market Attractiveness Analysis By Region

18. North America Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    18.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        18.3.1. By Country

            18.3.1.1. U.S.

            18.3.1.2. Canada

        18.3.2. By Product Type

        18.3.3. By Functionality

        18.3.4. By Material

        18.3.5. By Availability

        18.3.6. By Drug Modality

        18.3.7. By Therapeutic Class

        18.3.8. By End user

    18.4. Market Attractiveness Analysis

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

19. Latin America Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019

    19.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        19.3.1. By Country

            19.3.1.1. Brazil

            19.3.1.2. Mexico

            19.3.1.3. Argentina

            19.3.1.4. Rest of Latin America

        19.3.2. By Product Type

        19.3.3. By Functionality

        19.3.4. By Material

        19.3.5. By Availability

        19.3.6. By Drug Modality

        19.3.7. By Therapeutic Class

        19.3.8. By End user

    19.4. Market Attractiveness Analysis

    19.5. Market Trends

    19.6. Key Market Participants - Intensity Mapping

20. Europe Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031

    20.1. Introduction

    20.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    20.3. Market  Value (US$ Mn) Forecast By Market Taxonomy2021-2031

        20.3.1. By Country

            20.3.1.1. Germany

            20.3.1.2. Italy

            20.3.1.3. France

            20.3.1.4. U.K.

            20.3.1.5. Spain

            20.3.1.6. Russia

            20.3.1.7. Rest of Europe

        20.3.2. By Product Type

        20.3.3. By Functionality

        20.3.4. By Material

        20.3.5. By Availability

        20.3.6. By Drug Modality

        20.3.7. By Therapeutic Class

        20.3.8. By End user

    20.4. Market Attractiveness Analysis

    20.5. Market Trends

    20.6. Key Market Participants - Intensity Mapping

21. South Asia Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031

    21.1. Introduction

    21.2. Historical Market  Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    21.3. Market Value (US$ Mn) Forecast By Market Taxonomy2021-2031

        21.3.1. By Country

            21.3.1.1. India

            21.3.1.2. Thailand

            21.3.1.3. Indonesia

            21.3.1.4. Malaysia

            21.3.1.5. Rest of South Asia

        21.3.2. By Product Type

        21.3.3. By Functionality

        21.3.4. By Material

        21.3.5. By Availability

        21.3.6. By Drug Modality

        21.3.7. By Therapeutic Class

        21.3.8. By End user

    21.4. Market Attractiveness Analysis

    21.5. Market Trends

    21.6. Key Market Participants - Intensity Mapping

22. East Asia Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031

    22.1. Introduction

    22.2. Historical Market  Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    22.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        22.3.1. By Country

            22.3.1.1. China

            22.3.1.2. Japan

            22.3.1.3. South Korea

        22.3.2. By Product Type

        22.3.3. By Functionality

        22.3.4. By Material

        22.3.5. By Availability

        22.3.6. By Drug Modality

        22.3.7. By Therapeutic Class

        22.3.8. By End user

    22.4. Market Attractiveness Analysis

    22.5. Market Trends

    22.6. Key Market Participants - Intensity Mapping

23. Oceania Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031

    23.1. Introduction

    23.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    23.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        23.3.1. By Country

            23.3.1.1. Australia

            23.3.1.2. New Zealand

        23.3.2. By Product Type

        23.3.3. By Functionality

        23.3.4. By Material

        23.3.5. By Availability

        23.3.6. By Drug Modality

        23.3.7. By Therapeutic Class

        23.3.8. By End user

    23.4. Market Attractiveness Analysis

    23.5. Market Trends

    23.6. Key Market Participants - Intensity Mapping

24. Middle East and Africa Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031

    24.1. Introduction

    24.2. Historical Market Value (US$ Mn) Trend Analysis By  Value Taxonomy, 2016-2020

    24.3. Market Material (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        24.3.1. By Country

            24.3.1.1. GCC Countries

            24.3.1.2. Turkey

            24.3.1.3. South Africa

            24.3.1.4. Rest of Middle East and Africa

        24.3.2. By Product Type

        24.3.3. By Functionality

        24.3.4. By Material

        24.3.5. By Availability

        24.3.6. By Drug Modality

        24.3.7. By Therapeutic Class

        24.3.8. By End user

    24.4. Market Attractiveness Analysis

    24.5. Market Trends

25. Key & Emerging Countries Pharmaceutical Caps & Closure Market Analysis 2016-2020 and Forecast 2021-2031

    25.1. U.S. Pharmaceutical Caps & Closure Market Analysis

        25.1.1. By Product Type

        25.1.2. By Functionality

        25.1.3. By Material

        25.1.4. By Availability

        25.1.5. By Drug Modality

        25.1.6. By Therapeutic Class

        25.1.7. By End user

    25.2. Canada Pharmaceutical Caps & Closure Market Analysis

        25.2.1. By Product Type

        25.2.2. By Functionality

        25.2.3. By Material

        25.2.4. By Availability

        25.2.5. By Drug Modality

        25.2.6. By Therapeutic Class

        25.2.7. By End user

    25.3. By End User Brazil Pharmaceutical Caps & Closure Market Analysis

        25.3.1. By Product Type

        25.3.2. By Functionality

        25.3.3. By Material

        25.3.4. By Availability

        25.3.5. By Drug Modality

        25.3.6. By Therapeutic Class

        25.3.7. By End user

    25.4. Mexico Pharmaceutical Caps & Closure Market Analysis

        25.4.1. By Product Type

        25.4.2. By Functionality

        25.4.3. By Material

        25.4.4. By Availability

        25.4.5. By Drug Modality

        25.4.6. By Therapeutic Class

        25.4.7. By End user

    25.5. U.K. Pharmaceutical Caps & Closure Market Analysis

        25.5.1. By Product Type

        25.5.2. By Functionality

        25.5.3. By Material

        25.5.4. By Availability

        25.5.5. By Drug Modality

        25.5.6. By Therapeutic Class

        25.5.7. By End user

    25.6. Germany Pharmaceutical Caps & Closure Market Analysis

        25.6.1. By Product Type

        25.6.2. By Functionality

        25.6.3. By Material

        25.6.4. By Availability

        25.6.5. By Drug Modality

        25.6.6. By Therapeutic Class

        25.6.7. By End user

    25.7. France Pharmaceutical Caps & Closure Market Analysis

        25.7.1. By Product Type

        25.7.2. By Functionality

        25.7.3. By Material

        25.7.4. By Availability

        25.7.5. By Drug Modality

        25.7.6. By Therapeutic Class

        25.7.7. By End user

    25.8. Italy Pharmaceutical Caps & Closure Market Analysis

        25.8.1. By Product Type

        25.8.2. By Functionality

        25.8.3. By Material

        25.8.4. By Availability

        25.8.5. By Drug Modality

        25.8.6. By Therapeutic Class

        25.8.7. By End user

    25.9. Spain Pharmaceutical Caps & Closure Market Analysis

        25.9.1. By Product Type

        25.9.2. By Functionality

        25.9.3. By Material

        25.9.4. By Availability

        25.9.5. By Drug Modality

        25.9.6. By Therapeutic Class

        25.9.7. By End user

    25.10. Russia Pharmaceutical Caps & Closure Market Analysis

        25.10.1. By Product Type

        25.10.2. By Functionality

        25.10.3. By Material

        25.10.4. By Availability

        25.10.5. By Drug Modality

        25.10.6. By Therapeutic Class

        25.10.7. By End user

    25.11. China Pharmaceutical Caps & Closure Market Analysis

        25.11.1. By Product Type

        25.11.2. By Functionality

        25.11.3. By Material

        25.11.4. By Availability

        25.11.5. By Drug Modality

        25.11.6. By Therapeutic Class

        25.11.7. By End user

    25.12. Japan Pharmaceutical Caps & Closure Market Analysis

        25.12.1. By Product Type

        25.12.2. By Functionality

        25.12.3. By Material

        25.12.4. By Availability

        25.12.5. By Drug Modality

        25.12.6. By Therapeutic Class

        25.12.7. By End user

    25.13. South Korea Pharmaceutical Caps & Closure Market Analysis

        25.13.1. By Product Type

        25.13.2. By Functionality

        25.13.3. By Material

        25.13.4. By Availability

        25.13.5. By Drug Modality

        25.13.6. By Therapeutic Class

        25.13.7. By End user

    25.14. ASEAN Pharmaceutical Caps & Closure Market Analysis

        25.14.1. By Product Type

        25.14.2. By Functionality

        25.14.3. By Material

        25.14.4. By Availability

        25.14.5. By Drug Modality

        25.14.6. By Therapeutic Class

        25.14.7. By End user

    25.15. Australia Pharmaceutical Caps & Closure Market Analysis

        25.15.1. By Product Type

        25.15.2. By Functionality

        25.15.3. By Material

        25.15.4. By Availability

        25.15.5. By Drug Modality

        25.15.6. By Therapeutic Class

        25.15.7. By End user

    25.16. New Zealand Pharmaceutical Caps & Closure Market Analysis

        25.16.1. By Product Type

        25.16.2. By Functionality

        25.16.3. By Material

        25.16.4. By Availability

        25.16.5. By Drug Modality

        25.16.6. By Therapeutic Class

        25.16.7. By End user

    25.17. GCC Countries Pharmaceutical Caps & Closure Market Analysis

        25.17.1. By Product Type

        25.17.2. By Functionality

        25.17.3. By Material

        25.17.4. By Availability

        25.17.5. By Drug Modality

        25.17.6. By Therapeutic Class

        25.17.7. By End user

    25.18. South Africa Pharmaceutical Caps & Closure Market Analysis

        25.18.1. By Product Type

        25.18.2. By Functionality

        25.18.3. By Material

        25.18.4. By Availability

        25.18.5. By Drug Modality

        25.18.6. By Therapeutic Class

        25.18.7. By End user

26. Market Structure Analysis

    26.1. Market Analysis by Tier of Companies 

    26.2. Market Share Analysis of Top Players

    26.3. Market Presence Analysis

        26.3.1. Regional Footprint by Players

        26.3.2. Product Foot print by Players

27. Competition Analysis

    27.1. Competition Dashboard

    27.2. Competition Benchmarking

    27.3. Competition Deep Dive (Tentative List)

        27.3.1. Berry Global Group Inc.

            27.3.1.1. Overview

            27.3.1.2. Product Portfolio

            27.3.1.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.1.4. Sales Footprint

            27.3.1.5. Strategy Overview

                27.3.1.5.1. Marketing Strategy

                27.3.1.5.2. Product Strategy

                27.3.1.5.3. Channel Strategy

        27.3.2. WestRock Company

            27.3.2.1. Overview

            27.3.2.2. Product Portfolio

            27.3.2.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.2.4. Sales Footprint

            27.3.2.5. Strategy Overview

                27.3.2.5.1. Marketing Strategy

                27.3.2.5.2. Product Strategy

                27.3.2.5.3. Channel Strategy

        27.3.3. West Pharmaceutical Services, Inc.

            27.3.3.1. Overview

            27.3.3.2. Product Portfolio

            27.3.3.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.3.4. Sales Footprint

            27.3.3.5. Strategy Overview

                27.3.3.5.1. Marketing Strategy

                27.3.3.5.2. Product Strategy

                27.3.3.5.3. Channel Strategy 

        27.3.4. AptarGroup, Inc.

            27.3.4.1. Overview

            27.3.4.2. Product Portfolio

            27.3.4.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.4.4. Sales Footprint

            27.3.4.5. Strategy Overview

                27.3.4.5.1. Marketing Strategy

                27.3.4.5.2. Product Strategy

                27.3.4.5.3. Channel Strategy

        27.3.5. Amcor Plc.

            27.3.5.1. Overview

            27.3.5.2. Product Portfolio

            27.3.5.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.5.4. Sales Footprint

            27.3.5.5. Strategy Overview

                27.3.5.5.1. Marketing Strategy

                27.3.5.5.2. Product Strategy

                27.3.5.5.3. Channel Strategy

        27.3.6. Gerresheimer AG

            27.3.6.1. Overview

            27.3.6.2. Product Portfolio

            27.3.6.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.6.4. Sales Footprint

            27.3.6.5. Strategy Overview

                27.3.6.5.1. Marketing Strategy

                27.3.6.5.2. Product Strategy

                27.3.6.5.3. Channel Strategy

        27.3.7. Crown Holdings, Inc.

            27.3.7.1. Overview

            27.3.7.2. Product Portfolio

            27.3.7.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.7.4. Sales Footprint

            27.3.7.5. Strategy Overview

                27.3.7.5.1. Marketing Strategy

                27.3.7.5.2. Product Strategy

                27.3.7.5.3. Channel Strategy

        27.3.8. O. Berk Company, LLC

            27.3.8.1. Overview

            27.3.8.2. Product Portfolio

            27.3.8.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.8.4. Sales Footprint

            27.3.8.5. Strategy Overview

                27.3.8.5.1. Marketing Strategy

                27.3.8.5.2. Product Strategy

                27.3.8.5.3. Channel Strategy

        27.3.9. C.L. Smith Company

            27.3.9.1. Overview

            27.3.9.2. Product Portfolio

            27.3.9.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.9.4. Sales Footprint

            27.3.9.5. Strategy Overview

                27.3.9.5.1. Marketing Strategy

                27.3.9.5.2. Product Strategy

                27.3.9.5.3. Channel Strategy

        27.3.10. Drug Plastics & Glass Co Inc.

            27.3.10.1. Overview

            27.3.10.2. Product Portfolio

            27.3.10.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.10.4. Sales Footprint

            27.3.10.5. Strategy Overview

                27.3.10.5.1. Marketing Strategy

                27.3.10.5.2. Product Strategy

                27.3.10.5.3. Channel Strategy

        27.3.11. MOLD-RITE Plastics, LLC

            27.3.11.1. Overview

            27.3.11.2. Product Portfolio

            27.3.11.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.11.4. Sales Footprint

            27.3.11.5. Strategy Overview

                27.3.11.5.1. Marketing Strategy

                27.3.11.5.2. Product Strategy

                27.3.11.5.3. Channel Strategy 

        27.3.12. Aludium Group

            27.3.12.1. Overview

            27.3.12.2. Product Portfolio

            27.3.12.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.12.4. Sales Footprint

            27.3.12.5. Strategy Overview

                27.3.12.5.1. Marketing Strategy

                27.3.12.5.2. Product Strategy

                27.3.12.5.3. Channel Strategy

        27.3.13. United Caps Luxembourg S. A.

            27.3.13.1. Overview

            27.3.13.2. Product Portfolio

            27.3.13.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.13.4. Sales Footprint

            27.3.13.5. Strategy Overview

                27.3.13.5.1. Marketing Strategy

                27.3.13.5.2. Product Strategy

                27.3.13.5.3. Channel Strategy

        27.3.14. Weener Plastics Group B.V.

            27.3.14.1. Overview

            27.3.14.2. Product Portfolio

            27.3.14.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.14.4. Sales Footprint

            27.3.14.5. Strategy Overview

                27.3.14.5.1. Marketing Strategy

                27.3.14.5.2. Product Strategy

                27.3.14.5.3. Channel Strategy

        27.3.15. MENSHEN GmbH & Co. KG

            27.3.15.1. Overview

            27.3.15.2. Product Portfolio

            27.3.15.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.15.4. Sales Footprint

            27.3.15.5. Strategy Overview

                27.3.15.5.1. Marketing Strategy

                27.3.15.5.2. Product Strategy

                27.3.15.5.3. Channel Strategy

        27.3.16. BERICAP Holding GmbH

            27.3.16.1. Overview

            27.3.16.2. Product Portfolio

            27.3.16.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.16.4. Sales Footprint

            27.3.16.5. Strategy Overview

                27.3.16.5.1. Marketing Strategy

                27.3.16.5.2. Product Strategy

                27.3.16.5.3. Channel Strategy

        27.3.17. Albéa Group

            27.3.17.1. Overview

            27.3.17.2. Product Portfolio

            27.3.17.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.17.4. Sales Footprint

            27.3.17.5. Strategy Overview

                27.3.17.5.1. Marketing Strategy

                27.3.17.5.2. Product Strategy

                27.3.17.5.3. Channel Strategy

        27.3.18. DWK Life Sciences GmbH

            27.3.18.1. Overview

            27.3.18.2. Product Portfolio

            27.3.18.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.18.4. Sales Footprint

            27.3.18.5. Strategy Overview

                27.3.18.5.1. Marketing Strategy

                27.3.18.5.2. Product Strategy

                27.3.18.5.3. Channel Strategy

        27.3.19. Yantai Hicap Closures Co., Ltd.

            27.3.19.1. Overview

            27.3.19.2. Product Portfolio

            27.3.19.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.19.4. Sales Footprint

            27.3.19.5. Strategy Overview

                27.3.19.5.1. Marketing Strategy

                27.3.19.5.2. Product Strategy

                27.3.19.5.3. Channel Strategy 

        27.3.20. Parekhplast India Limited

            27.3.20.1. Overview

            27.3.20.2. Product Portfolio

            27.3.20.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.20.4. Sales Footprint

            27.3.20.5. Strategy Overview

                27.3.20.5.1. Marketing Strategy

                27.3.20.5.2. Product Strategy

                27.3.20.5.3. Channel Strategy

        27.3.21. Manaksia Limited

            27.3.21.1. Overview

            27.3.21.2. Product Portfolio

            27.3.21.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.21.4. Sales Footprint

            27.3.21.5. Strategy Overview

                27.3.21.5.1. Marketing Strategy

                27.3.21.5.2. Product Strategy

                27.3.21.5.3. Channel Strategy

        27.3.22. Parshva Exim Limited

            27.3.22.1. Overview

            27.3.22.2. Product Portfolio

            27.3.22.3. Profitability by Market Segments (Product/Channel/Regional)

            27.3.22.4. Sales Footprint

            27.3.22.5. Strategy Overview

                27.3.22.5.1. Marketing Strategy

                27.3.22.5.2. Product Strategy

                27.3.22.5.3. Channel Strategy

28. Assumptions and Acronyms Used

29. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 2: Global Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 3: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality

Table 4: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 5: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 6: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability

Table 7: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality

Table 8: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 9: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 10: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User

Table 11: Global Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031 By Region

Table 12: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 13: North America Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 14: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality

Table 15: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 16: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 17: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability

Table 18: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality

Table 19: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 20: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 21: North America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User

Table 22: North America Pharmaceutical Caps & Closure Market  Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country

Table 23: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 24: Latin America Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 25: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality

Table 26: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 27: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 28: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability

Table 29: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality

Table 30: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 31: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 32: Latin America Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User

Table 33: Latin America Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country

Table 34: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 35: Europe Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 36: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality

Table 37: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 38: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 39: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability

Table 40: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality

Table 41: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 42: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 43: Europe Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User

Table 44: Europe Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country

Table 45: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 46: South Asia Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 47: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality

Table 48: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 49: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 50: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability

Table 51: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality

Table 52: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 53: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 54: South Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User

Table 55: South Asia Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country

Table 56: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 57: East Asia Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 58: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality

Table 59: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 60: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 61: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability

Table 62: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality

Table 63: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 64: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 65: East Asia Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User

Table 66: East Asia Pharmaceutical Caps & Closure Market  Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country

Table 67: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 68: Oceania Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 69: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality

Table 70: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 71: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 72: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability

Table 73: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality

Table 74: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 75: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 76: Oceania Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User

Table 77: Oceania Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country

Table 78: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 79: Middle East and Africa Pharmaceutical Caps & Closure Market Demand Volume (in Units) Analysis- and Opportunity Assessment 2016–2031, By Product

Table 80: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Functionality

Table 81: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 82: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Material

Table 83: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Availability

Table 84: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Drug Modality

Table 85: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 86: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Therapeutic Class

Table 87: Middle East and Africa Pharmaceutical Caps & Closure Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User

Table 88: Middle East and Africa Pharmaceutical Caps & Closure Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2021–2031, By Country

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Pharmaceutical Caps & Closure Market Volume (in Units), 2016-2020

Figure 02: Global Pharmaceutical Caps & Closure Market Volume (in Units) & Y-o-Y Growth (%) Analysis, 2021–2031

Figure 03: Pharmaceutical Caps & Closure, Pricing Analysis per unit (US$), in 2020

Figure 04: Pharmaceutical Caps & Closure, Pricing Forecast per unit (US$), in 2031

Figure 05: Global Pharmaceutical Caps & Closure Market Value Analysis (US$ Mn), 2016-2020

Figure 06: Global Pharmaceutical Caps & Closure Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021–2031

Figure 07: Global Pharmaceutical Caps & Closure Market Absolute $ Opportunity, 2020 - 2031

Figure 08: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Product, 2021 & 2031

Figure 09: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Product, 2021-2031

Figure 10: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Product, 2021-2031

Figure 11: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Functionality, 2021 & 2031

Figure 12: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Functionality, 2021-2031

Figure 13: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Functionality, 2021-2031

Figure 14: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Material, 2021 & 2031

Figure 15: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Material, 2021-2031

Figure 16: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Material, 2021-2031

Figure 17: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Availability, 2021 & 2031

Figure 18: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Availability, 2021-2031

Figure 19: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Availability, 2021-2031

Figure 20: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Drug Modality, 2021 & 2031

Figure 21: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Drug Modality, 2021-2031

Figure 22: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Drug Modality, 2021-2031

Figure 23: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By Therapeutic Class, 2021 & 2031

Figure 24: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By Therapeutic Class, 2021-2031

Figure 25: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by Therapeutic Class, 2021-2031

Figure 26: Global Pharmaceutical Caps & Closure Market Share Analysis (%), By End User, 2021 & 2031

Figure 27: Global Pharmaceutical Caps & Closure Market Y-o-Y Analysis (%), By End User, 2021-2031

Figure 28: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis by End User, 2021-2031

Figure 29: Global Pharmaceutical Caps & Closure Market Share Analysis (%) By Region, 2021 & 2031

Figure 30: Global Pharmaceutical Caps & Closure Market Y-o-Y Growth (%) By Region, 2021–2031

Figure 31: Global Pharmaceutical Caps & Closure Market Attractiveness Analysis By Region, 2021–2031 

Figure 32: North America Pharmaceutical Caps & Closure Market Value Share By Product (2021E)

Figure 33: North America Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)

Figure 34: North America Pharmaceutical Caps & Closure Market Value Share By Material (2021E)

Figure 35: North America Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)

Figure 36: North America Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)

Figure 37: North America Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)

Figure 38: North America Pharmaceutical Caps & Closure Market Value Share By End User (2021E)

Figure 39: North America Pharmaceutical Caps & Closure Market Value Share By Country (2021E)

Figure 40: North America Pharmaceutical Caps & Closure Market  Value Analysis (US$ Mn), 2016–2020

Figure 41: North America Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031

Figure 42: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031

Figure 43: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031

Figure 44: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031

Figure 45: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031

Figure 46: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031

Figure 47: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031

Figure 48: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031

Figure 49: North America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031

Figure 50: Latin America Pharmaceutical Caps & Closure Market Value Share By Product (2021E)

Figure 51: Latin America Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)

Figure 52: Latin America Pharmaceutical Caps & Closure Market Value Share By Material (2021E)

Figure 53: Latin America Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)

Figure 54: Latin America Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)

Figure 55: Latin America Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)

Figure 56: Latin America Pharmaceutical Caps & Closure Market Value Share By End User (2021E)

Figure 57: Latin America Pharmaceutical Caps & Closure Market Value Share By Country (2021E)

Figure 58: Latin America Pharmaceutical Caps & Closure Market  Value Analysis (US$ Mn), 2016–2020

Figure 59: Latin America Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031

Figure 60: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031

Figure 61: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031

Figure 62: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031

Figure 63: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031

Figure 64: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031

Figure 65: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031

Figure 66: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031

Figure 67: Latin America Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031

Figure 68: Europe Pharmaceutical Caps & Closure Market Value Share By Product (2021E)

Figure 69: Europe Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)

Figure 70: Europe Pharmaceutical Caps & Closure Market Value Share By Material (2021E)

Figure 71: Europe Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)

Figure 72: Europe Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)

Figure 73: Europe Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)

Figure 74: Europe Pharmaceutical Caps & Closure Market Value Share By End User (2021E)

Figure 75: Europe Pharmaceutical Caps & Closure Market Value Share By Country (2021E)

Figure 76: Europe Pharmaceutical Caps & Closure Market  Value Analysis (US$ Mn), 2016–2020

Figure 77: Europe Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031

Figure 78: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031

Figure 79: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031

Figure 80: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031

Figure  81: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031

Figure 82: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031

Figure 83: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031

Figure 84: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031

Figure 85: Europe Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031

Figure 86: South Asia Pharmaceutical Caps & Closure Market Value Share By Product (2021E)

Figure 87: South Asia Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)

Figure 88: South Asia Pharmaceutical Caps & Closure Market Value Share By Material (2021E)

Figure 89: South Asia Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)

Figure 90: South Asia Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)

Figure 91: South Asia Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)

Figure 92: South Asia Pharmaceutical Caps & Closure Market Value Share By End User (2021E)

Figure 93: South Asia Pharmaceutical Caps & Closure Market Value Share By Country (2021E)

Figure 94: South Asia Pharmaceutical Caps & Closure Market  Value Analysis (US$ Mn), 2016–2020

Figure 95: South Asia Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031

Figure 96: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031

Figure 97: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031

Figure 98: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031

Figure 99: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031

Figure 100: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031

Figure 101: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031

Figure 102: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031

Figure 103: South Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031

Figure 104: East Asia Pharmaceutical Caps & Closure Market Value Share By Product (2021E)

Figure 105: East Asia Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)

Figure 106: East Asia Pharmaceutical Caps & Closure Market Value Share By Material (2021E)

Figure 107: East Asia Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)

Figure 108: East Asia Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)

Figure 109: East Asia Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)

Figure 110: East Asia Pharmaceutical Caps & Closure Market Value Share By End User (2021E)

Figure 111: East Asia Pharmaceutical Caps & Closure Market Value Share By Country (2021E)

Figure 112: East Asia Pharmaceutical Caps & Closure Market Value Analysis (US$ Mn), 2016–2020

Figure 113: East Asia Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031

Figure 114: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031

Figure 115: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031

Figure 116: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031

Figure 117: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031

Figure 118: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031

Figure 119: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031

Figure 120: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031

Figure 121: East Asia Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031

Figure 122: Oceania Pharmaceutical Caps & Closure Market Value Share By Product (2021E)

Figure 123: Oceania Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)

Figure 124: Oceania Pharmaceutical Caps & Closure Market Value Share By Material (2021E)

Figure 125: Oceania Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)

Figure 126: Oceania Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)

Figure 127: Oceania Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)

Figure 128: Oceania Pharmaceutical Caps & Closure Market Value Share By End User (2021E)

Figure 129: Oceania Pharmaceutical Caps & Closure Market Value Share By Country (2021E)

Figure 130: Oceania Pharmaceutical Caps & Closure Market  Value Analysis (US$ Mn), 2016–2020

Figure 131: Oceania Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031

Figure 132: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031

Figure 133: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031

Figure 134: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031

Figure 135: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031

Figure 136: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031

Figure 137: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031

Figure 138: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031

Figure 139: Oceania Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031

Figure 140: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Product (2021E)

Figure 141: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Functionality (2021E)

Figure 142: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Material (2021E)

Figure 143: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Availability (2021E)

Figure 144: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Drug Modality (2021E)

Figure 145: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Therapeutic Class (2021E)

Figure 146: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By End User (2021E)

Figure 147: Middle East and Africa Pharmaceutical Caps & Closure Market Value Share By Country (2021E)

Figure 148: Middle East and Africa Pharmaceutical Caps & Closure Market  Value Analysis (US$ Mn), 2016–2020

Figure 149: Middle East and Africa Pharmaceutical Caps & Closure Market Value Forecast (US$ Mn), 2021–2031

Figure 150: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Product, 2021–2031

Figure 151: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Functionality, 2021–2031

Figure 152: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Material, 2021–2031

Figure 153: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Availability, 2021–2031

Figure 154: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Drug Modality, 2021–2031

Figure 155: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Therapeutic Class, 2021–2031

Figure 156: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By End User, 2021–2031

Figure 157: Middle East and Africa Pharmaceutical Caps & Closure Market Attractiveness Analysis By Country, 2021–2031

Figure 158: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 159: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 160: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 161: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 162: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 163: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 164: U.S. Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 165: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 166: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 167: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 168: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 169: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 170: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 171: Canada Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 172: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 173: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 174: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 175: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 176: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 177: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 178: Brazil Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 179: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 180: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 181: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 182: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 183: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 184: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 185: Mexico Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 186: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 187: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 188: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 189: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 190: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 191: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 192: Argentina Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 193: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 194: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 195: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 196: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 197: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 198: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 199: U.K. Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 200: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 201: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 202: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 203: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 204: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 205: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 206: Germany Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 207: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 208: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 209: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 210: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 211: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 212: France Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 213: France Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 214: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 215: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 216: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 217: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 218: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 219: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 220: Italy Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 221: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 222: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 223: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 224: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 225: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 226: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 227: Spain Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 228: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 229: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 230: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 231: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 232: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 233: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 234: Russia Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 235: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 236: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 237: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 238: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 239: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 240: China Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 241: China Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 242: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 243: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 244: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 245: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 246: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 247: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 248: Japan Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 249: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 250: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 251: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 252: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 253: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 254: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 255: South Korea Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 256: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 257: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 258: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 259: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 260: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 261: India Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 262: India Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 263: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 264: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 265: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 266: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 267: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 268: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 269: Thailand Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 270: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 271: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 272: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 273: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 274: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 275: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 276: Malaysia Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 277: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 278: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 279: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 280: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 281: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 282: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 283: Indonesia Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 284: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 285: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 286: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 287: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 288: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 289: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 290: Australia Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 291: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 292: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 293: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 294: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 295: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 296: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 297: New Zealand Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 298: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 299: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 300: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 301: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 302: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 303: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 304: Turkey Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 305: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 306: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 307: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 308: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 309: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 310: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 311: GCC Countries Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Figure 312: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Product, 2021 & 2031

Figure 313: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Functionality, 2021 & 2031

Figure 314: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Material, 2021 & 2031

Figure 315: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Availability, 2021 & 2031

Figure 316: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Drug Modality, 2021 & 2031

Figure 317: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By Therapeutic Class, 2021 & 2031

Figure 318: South Africa Pharmaceutical Caps & Closure Market Share Analysis (%) By End user, 2021 & 2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Pharmaceutical Caps and Closures Market